Work

Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer in SWOG S1314.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.4506

Authors: Yi-Tsung Lu, Melissa Plets, Gareth Morrison, Alexander T. Cunha, Steven Y. Cen, Suhn K. Rhie, Kimberly Siegmund, Siamak Daneshmand, David I. Quinn, Joshua J Meeks, Seth P. Lerner, Daniel P. Petrylak, David James McConkey, Thomas W. Flaig, Ian M Thompson, Amir Goldkorn

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center, Keck Hospital of USC, Northwestern University, Baylor College of Medicine, Yale Cancer Center, Johns Hopkins University, Johns Hopkins Hospital, University of Colorado Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Conquer Cancer Foundation, Tower Cancer Research Foundation, National Institutes of Health

OpenAlex ID: W4281638492

Cites:

Cited by: 7

Related to: 10